| Similar Articles |
|---|
 |
The Motley Fool
December 2, 2010
Brian Orelli |
An Ounce of Prevention Gets Shot Down An FDA panel shoots down Merck's and Glaxo's prostate drugs.   |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
The Motley Fool
May 2, 2011
Brian Orelli |
Prostate Cancer Drug Roars Ahead Johnson & Johnson's buy of Cougar paid off, but look in the rear view mirror. |
The Motley Fool
May 4, 2009
Robert Steyer |
Beyond Provenge -- The Next Hot Cancer Drug? The search for prostate cancer treatments is filled with prospects and littered with failures. Which companies have the best chance of success? |
The Motley Fool
September 28, 2010
Brian Orelli |
Pfizer's Sutent Fails. Again! No surprise here. |
The Motley Fool
March 4, 2010
Brian Orelli |
Best in Class ... For Now Sanofi's new prostate cancer drug is better than nothing. |
AskMen.com
Jacob Franek |
Prostate Cancer Overview Everything you wanted to know and more about prostate cancer in this three-part prostate cancer guide. |
American Family Physician
May 15, 2005 |
Early Prostate Cancer: What You Should Know A patient hand-out on the disease, who is at risk, diagnosis and treatment options. |
The Motley Fool
June 29, 2005
Karl Thiel |
Cash In on the Future of Science With some diligence, you can ride your high school biology to biotech investing success. |
The Motley Fool
January 11, 2005
Charly Travers |
The Future of Cancer Vaccines Biotech companies developing cancer vaccines have been in investors' doghouses for a long time. Can a vaccine help stave off forms of the disease? |
AskMen.com
Jacob Franek |
Prostate Cancer Treatment And Prevention Everything you wanted to know about prostate cancer in our three-part Prostate Cancer Guide. |
AskMen.com
Jacob Franek |
Prostate Cancer Symptoms, Screening & Diagnosis Despite the facts that prostate cancer is the No. 1 cancer occurring in men (aside from skin cancers) and the second leading cause of cancer death (behind lung cancer), many men are still unfamiliar with this highly treatable disease. |
The Motley Fool
July 30, 2004
Roger Nusbaum |
Gilead Keeps Rolling Along Biotech can be a tough place to invest, but Gilead Sciences offers relative stability. |
| AskMen.com |
Cholesterol & The Prostate A new study suggests that men may be able to lower their risk of getting the most aggressive form of prostate cancer by keeping their cholesterol in a healthy range. |
AskMen.com
Alex Santoso |
Prostate Health 101 Most men don't have any clue about their prostate -- until things go wrong. With this information, they can maximize their prostate health. |
AskMen.com
Jen Woodward |
Prostate Cancer 101 Here are some of the basic facts about prostate cancer, along with what you can do to keep the C-word from gracing your medical chart. |
The Motley Fool
December 1, 2005
Brian Gorman |
Glaxo Follows the Biotechs The company's new focus on cancer drugs looks like a good move. Investors, take note. |
The Motley Fool
May 19, 2004
Roger Nusbaum |
Gilead Shines This biotech company looks strong because investors can relate to its products. |
BusinessWeek
June 13, 2005
Catherine Arnst |
Biotech, Finally The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. |
Chemistry World
February 11, 2009
Lewis Brindley |
Prostate Cancer Biomarker Could Speed Diagnosis US researchers have identified a compound in urine that could be used to detect prostate cancer - and also to distinguish between benign and invasive forms of the disease. |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
Salon.com
April 28, 2000
Dawn MacKeen |
A disease fueled by testosterone When a politician announces he has prostate cancer, what does it mean? |
AskMen.com
Jacob Franek |
Men's Health Charities A list of men's health charities worthy of holiday giving. |
| AskMen.com |
Good Health Care News New advice from the American Cancer Society puts a sharper focus on the risks of prostate cancer screening, emphasizing that annual testing can lead to unnecessary biopsies and treatments that do more harm than good. |
AskMen.com
Jacob Franek |
4 Fun Ways To Help Prevent Prostate Cancer We're not pretending that there's anything fun about prostate cancer. We are attempting to encourage men to take measures to prevent the disease. |
AskMen.com
March 17, 2001
Joshua Levine |
The Importance Of Regular Check-Ups For Men Men are much less likely than women to seek the routine medical care that they should. This article describes some of the risks. |
American Family Physician
September 15, 2005
Mark H. Ebell |
Point-of-Care Guides What is the risk of prostate cancer in a patient who is referred for biopsy? |
AskMen.com
April 15, 2014
Naomi Mead |
Don't Put Your Sexual Health At Risk! Eat These 5 Foods Right Now & Protect Yourself. It is believed that a high-sugar, high-fat, processed Western diet may have a significant part to play in the increased rates of prostate cancer we are now observing. |
American Family Physician
May 15, 2005
Bhatnagar & Kaplan |
Treatment Options for Prostate Cancer: Evaluating the Evidence Controversy surrounds the management options for localized prostate cancer-conservative management, prostatectomy, and radiation. Choosing among these options is difficult because of long-term side effects that include sexual, urinary, and bowel dysfunction. |
Nurse Practitioner
October 2009
Wallace et al. |
Shedding light on prostate cancer This article will discuss the risk factors, signs and symptoms, diagnosis of prostate cancer, and disease staging and grading, as well as necessary lab and diagnostic tests, treatment options and patient education. |
BusinessWeek
August 15, 2005 |
Misonix Zaps Prostate Cancer Misonix, a maker of medical and scientific gear, has investors interested in its new ultrasound device for prostate cancer. Shares have risen from $5.22 on Apr. 18 to $6.50 on Aug. 3. |
The Motley Fool
January 25, 2005
Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs. |
Managed Care
March 2007
Martin Sipkoff |
Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails. |
The Motley Fool
November 3, 2008
Brian Orelli |
Make Money, Fight Cancer Which prostate cancer fighting companies have promising investment potential? |
ifeminists
October 15, 2002
Sacks & Thompson |
When Men's Health Doesn't Count Congress is sending a message to American men: men's health doesn't count. |
